OSRH
Price
$4.22
Change
+$0.77 (+22.32%)
Updated
Feb 21 closing price
Capitalization
74.54M
VERA
Price
$28.58
Change
-$1.03 (-3.48%)
Updated
Feb 21 closing price
Capitalization
1.81B
25 days until earnings call
Ad is loading...

OSRH vs VERA

Header iconOSRH vs VERA Comparison
Open Charts OSRH vs VERABanner chart's image
OSR Holdings
Price$4.22
Change+$0.77 (+22.32%)
Volume$24.84M
Capitalization74.54M
Vera Therapeutics
Price$28.58
Change-$1.03 (-3.48%)
Volume$1.23M
Capitalization1.81B
OSRH vs VERA Comparison Chart
Loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OSRH vs. VERA commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSRH is a Hold and VERA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (OSRH: $4.22 vs. VERA: $28.58)
Brand notoriety: OSRH and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OSRH: 1539% vs. VERA: 137%
Market capitalization -- OSRH: $74.54M vs. VERA: $1.81B
OSRH [@Biotechnology] is valued at $74.54M. VERA’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OSRH’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • OSRH’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, OSRH is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERA’s TA Score shows that 4 TA indicator(s) are bullish.

  • VERA’s TA Score: 4 bullish, 5 bearish.

Price Growth

OSRH (@Biotechnology) experienced а +40.20% price change this week, while VERA (@Biotechnology) price change was +4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

VERA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.81B) has a higher market cap than OSRH($74.5M). VERA YTD gains are higher at: -32.419 vs. OSRH (-63.400).
OSRHVERAOSRH / VERA
Capitalization74.5M1.81B4%
EBITDAN/A-127.57M-
Gain YTD-63.400-32.419196%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A353M-
Total DebtN/A54.9M-
TECHNICAL ANALYSIS
Technical Analysis
VERA
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMFYX16.54-0.14
-0.84%
MassMutual Equity Opports Svc
ECSTX26.14-0.32
-1.21%
Eaton Vance Large-Cap Value C
BUFEX54.70-1.14
-2.04%
Buffalo Blue Chip Growth
MNRMX38.49-1.05
-2.66%
Manor
AHGCX10.07-0.35
-3.36%
American Century Heritage C

OSRH and

Correlation & Price change

A.I.dvisor indicates that over the last year, OSRH has been loosely correlated with IFRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OSRH jumps, then IFRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
+22.32%
IFRX - OSRH
34%
Loosely correlated
-1.08%
EDIT - OSRH
31%
Poorly correlated
-6.80%
VERA - OSRH
27%
Poorly correlated
-3.48%
EDSA - OSRH
22%
Poorly correlated
-2.80%
BIORQ - OSRH
8%
Poorly correlated
-2.04%
More